Drug Discovery Stories, Volume 2, 9780443338854
Paperback
Blockbuster drugs unveiled: science, discovery, and the future of medicine.
Pre-Order

Drug Discovery Stories, Volume 2

$542.61

  • Paperback

    600 pages

  • Release Date

    1 October 2025

Check Delivery Options

Summary

Unveiling the Secrets of Blockbuster Drugs: Drug Discovery Stories, Volume 2

Drug Discovery Stories, Volume Two showcases the discovery journeys of recent blockbuster drugs approved between 2023 and 2024, along with promising drug candidates. This book delves into structural biology, biological functions of targets, hit compound identification, hit-to-lead optimization, binding modes, key biological and pharmacokinetic data, and clinical results. It also covers other candidate compo…

Book Details

ISBN-13:9780443338854
ISBN-10:044333885X
Author:Bin Yu, Peng Zhan
Publisher:Elsevier - Health Sciences Division
Imprint:Elsevier - Health Sciences Division
Format:Paperback
Number of Pages:600
Release Date:1 October 2025
Weight:0g
Dimensions:276mm x 216mm
About The Author

Bin Yu

Professor Bin Yu obtained his PhD degree from Zhengzhou University and University of Cambridge and currently is a professor of medicinal chemistry at School of Pharmaceutical Sciences, Zhengzhou University. His research interests focus on chemistry driven drug discovery for novel therapeutics. To date, he has published over 120 papers in international high-impact peer-reviewed journals including Journal of Medicinal Chemistry, Organic Letters, Pharmacology & Therapeutics, Journal of Hematology & Oncology, Drug Discovery Today, Acta Pharmaceutica Sinica B, etc., 10 of them were published in journal with impact factor (IF) >10.

Peng Zhan obtained his B.S. degree from Shandong University, China, in 2005. He then earned his M.S. and Ph.D. degrees in medicinal chemistry from Shandong University in 2008 and 2010. He subsequently joined Shandong University as a Lecturer (2010−2012). From 2012 to 2014, he worked as a postdoctoral fellow funded by Japan Society for the Promotion of Science. He is currently a full professor in the Department of Medicinal Chemistry, Shandong University. His research interests involve the discovery of novel anti-viral (HIV, HBV, influenza, coronavirus, etc.), anti-gout, and anti-cancer agents based on rational drug design and combinatorial chemistry approaches. He also co-edited six books published by People’s Medical Publishing House and Springer Nature, respectively and granted 50 patents (30 of them licensed). He currently serves as advisory editorial board member of Journal of Medicinal Chemistry.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.